Lymphodepletion followed by adoptive cell transfer (ACT) of autologous, tumor-reactive T
cells boosts antitumor immunotherapeutic activity in mouse and in humans. In the most recent …

CD4+ CD25+ T regulatory (T reg) cells control immunologic tolerance to self-antigens and
play a role in suppressing antitumor immune responses, but the mechanism of suppression in …

Parkinson's disease (PD) is a major neurodegenerative chronic disease, most likely caused
by a complex interplay of genetic and environmental factors. Information on various aspects …

Depletion of immune elements before adoptive cell transfer (ACT) can dramatically improve
the antitumor efficacy of transferred CD8 + T cells, but the specific mechanisms that …

Central memory CD8 + T cells (T CM ) and effector memory CD8 + T cells (T EM ) are found
in humans and mice; however, their relative contributions to host immunity have only …

Many tumor-associated antigens are derived from nonmutated “self” proteins. T cells infiltrating
tumor deposits recognize self-antigens presented by tumor cells and can be expanded in …

CD4 + T cells can differentiate into multiple effector subsets, but the potential roles of these
subsets in anti-tumor immunity have not been fully explored. Seeking to study the impact of …

Adoptive transfer of large numbers of tumor-reactive CD8 + cytotoxic T lymphocytes (CTLs)
expanded and differentiated in vitro has shown promising clinical activity against cancer. …

CD4+ T cells control the effector function, memory, and maintenance of CD8+ T cells.
Paradoxically, we found that absence of CD4+ T cells enhanced adoptive immunotherapy of …

IL-15 and IL-2 possess similar properties, including the ability to induce T cell proliferation.
However, whereas IL-2 can promote apoptosis and limit CD8 + memory T cell survival and …